15.05.2017 | Fundraising
ZAG-S&W represented BiomX in $24 million Series A financing.
Adv. Shy Baranov from the International Department advised the biomed company BiomX in raising $24 million in its first financing round.
BiomX, formerly MBCure, was founded in the Futurx Technology Incubator. It develops innovative drugs to treat a variety of diseases caused by microbial imbalance.
The funds will be used to advance the company’s pharmaceutical research involving the development of human clinical trials and the continuation of technological development.